The correlation between PSMA PET/CT uptake and [177Lu]Lu-PSMA-I&T absorbed dose in Metastatic Castration-Resistant Prostate Cancer Patients.

被引：0
|
作者：
Kalloe, V. [1 ]
Owers, E. C. [1 ]
de Boer, M. M. [1 ]
Rijkhorst, E. [1 ]
Aalbersberg, E. A. [1 ]
Dotinga, M. [1 ]
机构：
[1] Antoni van Leeuwenhoek, Amsterdam, Netherlands
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2024年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EPS-286
引用
收藏
页码：S424 / S424
页数：1
相关论文
共 50 条
  • [41] LuCAB: A PHASE I/II TRIAL EVALUATING CABAZITAXEL IN COMBINATION WITH (177Lu)Lu-PSMA-617 IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
    Buteau, James
    INTERNAL MEDICINE JOURNAL, 2023, 53 : 71 - 71
  • [42] Personalized dosimetry assessment of [177Lu]Lu-PSMA-617 radioligand therapy in the management of metastatic castration-resistant prostate cancer
    Kazemi-Jahromi, Mahmood
    Yazdani, Elmira
    Karamzade-Ziarati, Najme
    Asadi, Mahboobeh
    Sadeghi, Mahdi
    Geramifar, Parham
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2024, 100 (11) : 1551 - 1559
  • [43] Comparison of Posttherapy 4-and 24-Hour [177Lu]Lu-PSMA SPECT/CT and Pretherapy PSMA PET/CT in Assessment of Disease in Men with Metastatic Castration-Resistant Prostate Cancer
    Swiha, Mina
    Pathmanandavel, Sarennya
    Papa, Nathan
    Sabahi, Zahra
    Li, Sherrington
    Zheng, Alex
    Khan, Sobia
    Ayers, Maria
    Sharma, Shikha
    Crumbaker, Megan
    Nguyen, Andrew
    Chan, Lyn
    Ayati, Narjess
    Emmett, Louise
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (12) : 1939 - 1944
  • [44] Radiation Dosimetry for 177Lu-PSMA I&T in Metastatic Castration-Resistant Prostate Cancer: Absorbed Dose in Normal Organs and Tumor Lesions
    Okamoto, Shozo
    Thieme, Anne
    Allmann, Jakob
    D'Alessandria, Calogero
    Maurer, Tobias
    Retz, Margitta
    Tauber, Robert
    Heck, Matthias M.
    Wester, Hans-Juergen
    Tamaki, Nagara
    Fendler, Wolfgang P.
    Herrmann, Ken
    Pfob, Christian H.
    Scheidhauer, Klemens
    Schwaiger, Markus
    Ziegler, Sibylle
    Eiber, Matthias
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (03) : 445 - 450
  • [45] Clinical protocols to monitor efficacy of [177Lu]Lu-PSMA radiopharmaceutical therapy in metastatic castration-resistant prostate cancer.
    Unterrainer, Lena
    De Leiris, Nicolas
    Unterrainer, Marcus
    Ilhan, Harun
    Delker, Astrid
    Hempel, Linus
    Ells, Zachary
    Zahner, Joseph
    Holzgreve, Adrien
    Zacherl, Mathias J.
    Casuscelli, Jozefina
    Kiraz, Kevin
    Leenhardt, Julien
    Jacquet, Emmanuelle
    Long, Jerome
    Laramas, Mathieu
    Paller, Channing Judith
    Solnes, Lilja B.
    Gafita, Andrei
    Djaileb, Loic
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL) : 39 - 39
  • [46] Evaluation of Nephrotoxicity of Extended Lu177-PSMA in Patients with Metastatic Castration-Resistant Prostate Cancer
    Topal, E.
    Kovan, B.
    Simsek, D. Has
    Civan, C.
    Sanli, M.
    Basaran, M.
    Sanli, Y.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S151 - S152
  • [47] Pretherapeutic Comparative Dosimetry of 177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer
    Feuerecker, Benedikt
    Chantadisai, Maythinee
    Allmann, Anne
    Tauber, Robert
    Allmann, Jakob
    Steinhelfer, Lisa
    Rauscher, Isabel
    Wurzer, Alexander
    Wester, Hans-Juergen
    Weber, Wolfgang A.
    d'Alessandria, Calogero
    Eiber, Matthias
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (06) : 833 - 839
  • [48] The role of Ga68 PSMA PET/CT imaging in Lu177 PSMA treatment planning in metastatic castration-resistant prostate cancer
    Erdogan, Mehmet
    Sengul, Sevim S.
    Cetin, Bulent
    Avci, Mustafa
    Yagci, Samet
    Ozkoc, Ismail
    Barikan, Damla Ezgi
    Yildiz, Mustafa
    ANNALS OF NUCLEAR MEDICINE, 2022, 36 (06) : 562 - 569
  • [49] The role of Ga68 PSMA PET/CT imaging in Lu177 PSMA treatment planning in metastatic castration-resistant prostate cancer
    Mehmet Erdogan
    Sevim S. Sengul
    Bulent Cetin
    Mustafa Avcı
    Samet Yagci
    Ismail Ozkoç
    Damla Ezgi Barikan
    Mustafa Yildiz
    Annals of Nuclear Medicine, 2022, 36 : 562 - 569
  • [50] 177Lu-PSMA-RLT of metastatic castration-resistant prostate cancer: limitations and improvements
    Jianpeng Cao
    Yue Chen
    Mei Hu
    Wei Zhang
    Annals of Nuclear Medicine, 2021, 35 : 861 - 870
12345